Evidence map›Paper›PMID 21889444›Full record

ArticleBiophysical journal2011

Biomimetic N-terminal alkylation of peptoid analogues of surfactant protein C.

Nathan J Brown, Michelle T Dohm, Jorge Bernardino de la Serna, Annelise E Barron

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The role of surfactant in respiratory distress syndrome.The open respiratory medicine journal · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nathan J BrownDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, USA.
Michelle T Dohm
Jorge Bernardino de la Serna
Annelise E Barron
Northwestern University · USStanford University · USUniversity of Southern Denmark · DK

Funding

Development of a Biomimetic Lung Surfactant ReplacementR01HL067984 · NHLBI · STANFORD UNIVERSITY · PI BARRON, ANNELISE EMILY · 2001 to 2010
$2.5M
NHLBI NIH HHS 2 R01 HL67984NHLBI NIH HHS R01 HL067984
6 · The paper itself

Abstract

Surfactant protein C (SP-C) is a hydrophobic lipopeptide that is critical for lung function, in part because it physically catalyzes the formation of surface-associated surfactant reservoirs. Many of SP-C's key biophysical properties derive from its highly stable and hydrophobic α-helix. However, SP-C's posttranslational modification with N-terminal palmitoyl chains also seems to be quite important. We created a new (to our knowledge) class of variants of a synthetic, biomimetic family of peptide mimics (peptoids) that allow us to study the functional effects of biomimetic N-terminal alkylation in vitro. Mimics were designed to emulate the amphipathic patterning, helicity, and hydrophobicity of SP-C, and to include no, one, or two vicinal amide-linked, N-terminal octadecyl chains (providing a reach equivalent to that of natural palmitoyl chains). Pulsating bubble surfactometry and Langmuir-Wilhelmy surface balance studies showed that alkylation improved biomimetic surface activities, yielding lower film compressibility and lower maximum dynamic surface tensions. Atomic force microscopy studies indicated that alkyl chains bind to and retain segregated interfacial surfactant phases at low surface tensions by inducing 3D structural transitions in the monolayer's fluid-like phase, forming surfactant-associated reservoirs. Peptoid-based SP-C mimics are easily produced and purified, and offer much higher chemical and secondary structure stability than polypeptide-based mimics. In surfactant replacements intended for medical use, synthetic SP mimics reduce the odds of pathogen contamination, which may facilitate the wider use of surfactant treatment of respiratory disorders and diseases.

Indexed as

Drug DesignAlkylationAmino Acid SequenceBiomimetic MaterialsHumansHydrophobic and Hydrophilic InteractionsMicroscopy, Atomic ForceMicroscopy, FluorescencePeptoidsProtein Structure, SecondaryPulmonary Surfactant-Associated Protein CSurface PropertiesPeptoidsPulmonary Surfactant-Associated Protein C

Identifiers

PMID21889444
PMCPMC3164185
OpenAlexW2032259918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.